FLOMATRIXX Trademark

Trademark Overview

On Monday, November 20, 2023, a trademark application was filed for FLOMATRIXX with the United States Patent and Trademark Office. The USPTO has given the FLOMATRIXX trademark a serial number of 98278456. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, January 7, 2025. This trademark is owned by Gel4Med, Inc.. The FLOMATRIXX trademark is filed in the Pharmaceutical Products category with the following description:

synthetic peptides for tissue repair or regeneration
flomatrixx

General Information

Serial Number98278456
Word MarkFLOMATRIXX
Filing DateMonday, November 20, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, January 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements

Goods and Servicessynthetic peptides for tissue repair or regeneration

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 3, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGel4Med, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLowell, MA 01852
Party NameGel4Med, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLowell, MA 01852

Trademark Events

Event DateEvent Description
Thursday, November 23, 2023NEW APPLICATION ENTERED
Wednesday, January 3, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 12, 2024ASSIGNED TO EXAMINER
Friday, June 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 14, 2024NON-FINAL ACTION WRITTEN
Friday, June 14, 2024NON-FINAL ACTION E-MAILED
Thursday, September 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 5, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 12, 2024NON-FINAL ACTION WRITTEN
Thursday, September 12, 2024NON-FINAL ACTION E-MAILED
Thursday, September 12, 2024FINAL REFUSAL WRITTEN
Thursday, September 12, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 12, 2024FINAL REFUSAL E-MAILED
Thursday, September 12, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, October 31, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 31, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 31, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, November 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 26, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

flomatrixx regeneration repair tissue peptides synthetic